DAVITA INC (DVA) Stock Price, Quote, News and Overview
NYSE:DVA - New York Stock Exchange, Inc. - US23918K1088 - Common Stock - Currency: USD
DVA Quote, Performance and Key Statistics
135.38
+0.99 (+0.74%)
The current stock price of DVA is 135.38 USD. In the past month the price decreased by -4.09%. In the past year, price decreased by -9.93%.
DVA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.82 | 86.78B | ||
| CI | THE CIGNA GROUP | 10.57 | 79.24B | ||
| LH | LABCORP HOLDINGS INC | 17.86 | 22.47B | ||
| DGX | QUEST DIAGNOSTICS INC | 19 | 20.10B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.29 | 14.72B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.32 | 13.88B | ||
| HIMS | HIMS & HERS HEALTH INC | 57.53 | 10.30B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.34B | ||
| CHE | CHEMED CORP | 19.9 | 6.51B | ||
| RDNT | RADNET INC | 187.36 | 5.19B | ||
| OPCH | OPTION CARE HEALTH INC | 20.98 | 4.64B | ||
| HNGE | HINGE HEALTH INC-A | N/A | 4.61B |
Related stock screener links
About DVA
Company Profile
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 76,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Company Info
DAVITA INC
2000 16th St
Denver COLORADO 80202 US
CEO: Javier J. Rodriguez
Employees: 76000
Phone: 13105362668
DAVITA INC / DVA FAQ
What is the stock price of DAVITA INC today?
The current stock price of DVA is 135.38 USD. The price increased by 0.74% in the last trading session.
What is the ticker symbol for DAVITA INC stock?
The exchange symbol of DAVITA INC is DVA and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is DVA stock listed?
DVA stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for DAVITA INC stock?
17 analysts have analysed DVA and the average price target is 163.75 USD. This implies a price increase of 20.96% is expected in the next year compared to the current price of 135.38. Check the DAVITA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DAVITA INC worth?
DAVITA INC (DVA) has a market capitalization of 10.22B USD. This makes DVA a Large Cap stock.
How many employees does DAVITA INC have?
DAVITA INC (DVA) currently has 76000 employees.
What are the support and resistance levels for DAVITA INC (DVA) stock?
DAVITA INC (DVA) has a support level at 129.49 and a resistance level at 138.6. Check the full technical report for a detailed analysis of DVA support and resistance levels.
Is DAVITA INC (DVA) expected to grow?
The Revenue of DAVITA INC (DVA) is expected to grow by 5.9% in the next year. Check the estimates tab for more information on the DVA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DAVITA INC (DVA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DVA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DVA, evaluating the profitability, health, valuation and growth aspects
- DAVITA INC (DVA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DAVITA INC (DVA) Sales and EPS estimates to see what analysts future expectations are.
- DAVITA INC (DVA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DAVITA INC (DVA) Insider and Institutional Ownership to learn about the owners and their transactions.
- DAVITA INC (DVA) Stock Chart to make your own analysis
- DAVITA INC (DVA) Latest news and press-releases to stay up to date.
Does DAVITA INC (DVA) stock pay dividends?
DVA does not pay a dividend.
When does DAVITA INC (DVA) report earnings?
DAVITA INC (DVA) will report earnings on 2025-10-27, after the market close.
What is the Price/Earnings (PE) ratio of DAVITA INC (DVA)?
The PE ratio for DAVITA INC (DVA) is 13.97. This is based on the reported non-GAAP earnings per share of 9.69 and the current share price of 135.38 USD. Check the full fundamental report for a full analysis of the valuation metrics for DVA.
What is the Short Interest ratio of DAVITA INC (DVA) stock?
The outstanding short interest for DAVITA INC (DVA) is 15.41% of its float. Check the ownership tab for more information on the DVA short interest.
DVA Technical Analysis
DVA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DVA. DVA has an excellent profitability rating, but there are some minor concerns on its financial health.
DVA Financial Highlights
Over the last trailing twelve months DVA reported a non-GAAP Earnings per Share(EPS) of 9.69. The EPS increased by 7.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.35% | ||
| ROA | 4.78% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
DVA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 53% to DVA. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of 14.11% and a revenue growth 5.9% for DVA